Metabolic syndrome and cerebral vasomotor reactivity

European Journal of Neurology

Volumn 17, Issue 12, 2010, Pages 1457-1462

  Giannopoulos, S ^a,b   Boden Albala, B ^a,c   Choi, J H ^a   Carrera, E ^a   Doyle, M ^a   Perez, T ^a   Marshall, R S ^a  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF IOANNINA   (Greece)

^c Mailman School of Public Health ^*  (United States)

Author keywords

Cerebral vasomotor reactivity; CO2 reactivity; Ischaemic stroke; Metabolic syndrome

Indexed keywords

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CARBON DIOXIDE BREATHING; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; FLOW RATE; HEMISPHERE; HUMAN; MALE; MEDICAL RECORD REVIEW; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS; VASOMOTOR REFLEX;

BRAIN; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REGIONAL BLOOD FLOW; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOMOTOR SYSTEM;

EID: 78649616033     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03087.x     Document Type: Article

References (31)

1. Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association; National Heart Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome. An American Heart Association Statement. Executive Summary. Circulation 2005; 112: 2735-2752.
2. Wild SH, Byrne CD, Tzoulaki I, et al. Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: the Edinburgh Artery Study. Atherosclerosis 2009; 203: 604-609.
3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
4. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007; 92: 399-404.
5. Boden-Albala B, Sacco RL, Lee HS, et al. Metabolic Syndrome and Ischemic Stroke Risk. Northern Manhattan Study. Stroke 2008; 39: 30-35.
6. Rodriguez-Colon SM, Mo J, Duan Y, et al. Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study. Stroke 2009; 40: 200-205.
7. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414.
8. 2 to acetazolamide. J Cereb Blood Flow Metab 1992; 12: 162-168.
9. Silvestrini M, Vernieri F, Pasqualetti P, et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000; 283: 2122-2127.
10. Marshall RS, Rundek T, Sproule DM, Fitzsimmons BF, Schwartz S, Lazar RM. Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease. Stroke 2003; 34: 945-949.
11. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 1998; 78: 53-97.
12. Inzitari D, Eliasziw M, Gates P, et al. The causes and risk of stroke in patients with asymptomatic internal carotid artery stenosis. NASCET Collaborators. N Engl J Med 2000; 342: 1693-1700.
13. Grant EG, Benson CB, Moneta GL, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis - Society of Radiologists in Ultrasound Consensus conference. Radiology 2003; 229: 340-346.
14. Markus H, Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 2001; 124: 457-467.
15. Air EL, Kissela BM. Diabetes, the Metabolic Syndrome, and Ischemic Stroke. Diabetes Care 2007; 30: 3131-3140.
16. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management. Nutr Metab Cardiovasc Dis 2010; 20: 140-146.
17. Suzuki T, Hirata K, Elkind MS, et al. Metabolic Syndrome, endothelial dysfunction and the risk of cardiovascular events: the Northern Manhattan Study. Am Heart J 2008; 156: 405-410.
18. Lavi S, Gaitini D, Milloul V, Jacob G. Impaired cerebral CO2 vasoreactivity: association with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2006; 291: H1856-H1861.
19. Bang OY, Kim JW, Lee JH, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005; 65: 296-298.
20. Park JH, Kwon HM, Roh JK. Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur J Neurol 2007; 14: 379-386.
21. Shahar E, Chambless LE, Rosamond WD, et al. ; Atherosclerosis Risk in Communities Study. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2003; 34: 623-631.
22. Domoki F, Perciaccante JV, Shimizu K, Puskar M, Busija DW, Bari F. N-methyl-D-aspartate-induced vasodilation is mediated by endothelium-independent nitric oxide release in piglets. Am J Physiol Heart Circ Physiol 2002; 282: H1404-H1409.
23. Last D, Alsop DC, Abduljalil AM, et al. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 2007; 30: 1193-1199.
24. Novak V, Last D, Alsop DC, et al. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care 2006; 29: 1529-1534.
25. Hoffman WH, Litaker MS, Pluta RM, Camens ML. Cerebral vasoreactivity in children and adolescents with type 1 diabetes mellitus. Endocr Res 2004; 30: 315-325.
26. Leoncini G, Ratto E, Viazzi F, et al. Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. J Hum Hypertens 2007; 21: 802-807.
27. Cuspidi C, Meani S, Valerio C, et al. Age and target organ damage in essential hypertension: role of the metabolic syndrome. Am J Hypertens 2007; 20: 296-303.
28. Sander K, Hof U, Poppert H, Conrad B, Sander D. Improved cerebral vasoreactivity after statin administration in healthy adults. J Neuroimaging 2005; 15: 266-270.
29. Kosmidou M, Hatzitolios AI, Adamidou A, et al. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension. Am J Hypertens 2008; 21: 303-309.
30. Rosengarten B, Auch D, Kaps M. Effects of initiation and acute withdrawal of statins on the neurovascular coupling mechanism in healthy, normocholesterolemic humans. Stroke 2007; 38: 3193-3197.
31. Settakis G, Molnar C, Kerenyi L, et al. Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature. Eur J Neurol 2003; 10: 609-620.